Veritas is taking preventive genomic medicine to Repsol’s entire workforce in Spain. November 21, 2022
A recent study demonstrates that genetic information provided by Whole Genome Sequencing (WGS) can help detect diseases at an earlier stage and give greater precision to screening and health optimization in general practice. October 28, 2022
Veritas takes its innovative prevention based genetic services portfolio to the European Society of Human Genetics (ESHG) Conference 2022 and will present results from WGS genomic screenings in 400 patients from the Clínica Universidad de Navarra June 9, 2022
Charme Capital Partners and Amadeus Capital Partners agree the sale of Veritas Intercontinental to LetsGetChecked March 29, 2022
Veritas brings new clinical updates to myGenome, its whole genome sequencing based comprehensive genetic risk screening service. October 26, 2021
